NGNE vs CRD-A

Comparison between Neoleukin Therapeutics Inc (NGNE, Company) and Crawford & Co. - Class A (CRD-A, Company).

NGNE is from the Healthcare sector, while CRD-A is from the Financial Services sector.

5-Year PerformanceCRD-A has outperformed NGNE, delivering a return of +3.7% compared to -26.0%

NGNE vs CRD-A - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NGNE(COMPANY)	CRD-A(COMPANY)
Market Cap	$564M	$569M
Max Drawdown	98.34%	84.40%
Sharpe Ratio	0.98	0.16
5Y Beta	1.89	0.81
Industry	Biotechnology	Insurance Brokers
P/E Ratio	-5.52	15.66
Forward P/E	N/A	12.48
PEG Ratio	-0.44	N/A
Dividend Yield	N/A	2.72%
5Y Dividends CAGR	N/A	4.56%
5Y EPS CAGR	11.24%	N/A
Debt to Equity	0.00%	24.68%
Free Cash Flow Yield	-14.76%	19.55%

Market Cap

NGNE

$564M

Winner

CRD-A

$569M

Max Drawdown

NGNE

98.34%

Winner

CRD-A

84.40%

Sharpe Ratio

Winner

NGNE

0.98

CRD-A

0.16

5Y Beta

NGNE

1.89

Winner

CRD-A

0.81

Industry

NGNE

Biotechnology

CRD-A

Insurance Brokers

P/E Ratio

Winner

NGNE

-5.52

CRD-A

15.66

Forward P/E

NGNE

N/A

CRD-A

12.48

PEG Ratio

NGNE

-0.44

CRD-A

N/A

Dividend Yield

NGNE

N/A

CRD-A

2.72%

5Y Dividends CAGR

NGNE

N/A

CRD-A

4.56%

5Y EPS CAGR

NGNE

11.24%

CRD-A

N/A

Debt to Equity

Winner

NGNE

0.00%

CRD-A

24.68%

Free Cash Flow Yield

NGNE

-14.76%

Winner

CRD-A

19.55%

NGNE vs CRD-A - Historical Returns

Returns include dividend reinvestment.

Period	NGNE	CRD-A
1 month	+15.26%	-6.36%
3 months	+31.99%	+0.62%
6 months	+94.27%	+1.44%
1 year	+54.05%	+1.30%
5 years(CAGR)	-25.99%	+3.69%
10 years(CAGR)	-13.72%	+4.81%
Max(CAGR)	-14.26%	+2.81%

Winner

NGNE

+15.26%

CRD-A

-6.36%

Winner

NGNE

+31.99%

CRD-A

+0.62%

Winner

NGNE

+94.27%

CRD-A

+1.44%

Winner

NGNE

+54.05%

CRD-A

+1.30%

5Y(CAGR)

NGNE

-25.99%

Winner

CRD-A

+3.69%

10Y(CAGR)

NGNE

-13.72%

Winner

CRD-A

+4.81%

Max(CAGR)

NGNE

-14.26%

Winner

CRD-A

+2.81%

NGNE vs CRD-A - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	NGNE	CRD-A
2026	+76.44%	+0.04%
2025	-10.00%	+1.73%
2024	+15.05%	-7.92%
2023	+91.88%	+147.47%
2022	-90.27%	-25.48%
2021	-65.89%	+8.09%
2020	+18.99%	-32.56%
2019	+428.76%	+34.22%
2018	-82.00%	+7.57%
2017	-27.41%	-6.49%
2016	+33.90%	+97.00%
2015	+63.56%	-38.28%
2014	-37.24%	+15.94%
2013	N/A	+36.90%
2012	N/A	+49.04%
2011	N/A	+70.23%
2010	N/A	-24.53%
2009	N/A	-56.34%
2008	N/A	+86.70%
2007	N/A	-42.62%
2006	N/A	+4.59%
2005	N/A	-10.39%
2004	N/A	+3.60%
2003	N/A	+76.03%
2002	N/A	-49.92%
2001	N/A	-9.05%
2000	N/A	-3.54%
1999	N/A	+0.09%

NGNE vs CRD-A Drawdown Comparison

The maximum drawdown for NGNE was -98.34%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The maximum drawdown for CRD-A was -82.82%, occurring on Sep 27, 2010. Recovery took 1997 trading sessions.

The current NGNE drawdown is -91.96%. The current CRD-A drawdown is -14.45%.

Rank	NGNE	CRD-A
#1	-98.34% Aug 14, 2015 - Apr 8, 2025	-82.82% Aug 11, 2008 - Jul 18, 2016
#2	-89.57% Mar 12, 2014 - Aug 10, 2015	-70.16% Mar 18, 2002 - Aug 11, 2008
#3	-16.18% Aug 11, 2015 - Aug 14, 2015	-52.67% Dec 16, 2019 - Jun 16, 2023
#4	N/A	-40.76% Feb 26, 2024 - Mar 11, 2024
#5	N/A	-32.87% Nov 21, 2016 - Feb 1, 2019
#6	N/A	-30.76% Jun 29, 2001 - Mar 18, 2002
#7	N/A	-20.81% Mar 5, 2019 - Jun 27, 2019
#8	N/A	-19.53% Jun 30, 2023 - Nov 20, 2023
#9	N/A	-17.94% Jan 11, 2000 - Jun 20, 2001
#10	N/A	-12.24% Jul 18, 2016 - Nov 11, 2016
#11	N/A	-11.15% Dec 29, 2023 - Feb 15, 2024
#12	N/A	-9.95% Jul 15, 2019 - Sep 12, 2019
#13	N/A	-8.21% Feb 19, 2019 - Mar 1, 2019
#14	N/A	-5.83% Nov 2, 1999 - Dec 22, 1999
#15	N/A	-5.70% Sep 30, 2019 - Nov 13, 2019

Correlation

Correlation between NGNE and CRD-A is -0.54 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.54

-101